The group’s principal activity is to unique solutions for the respiratory, dermatology and psychiatry markets. The group products include Aquoral(TM), Zinx(TM), Akurza(TM), Xyralid(TM), Extendryl(R) and Levall(R). The group marketed its products under the trade names Extendryl(R) and Levall(R). The group operates from the United States. In the year 2006, the group acquired by Multi-Link.The group’s revenue in the year 2006 was $ 6,192,905.
